Vor BioPharma

Forecast & Rating9 analysts currently cover Vor BioPharma, with about 88.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $39.00, about 74.7% upside from the current price of $22.32. Price targets range from $27.00 to $50.00 — a wide spread, showing clear disagreement over just how much Vor BioPharma can rise. Historically, about 1.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Vor BioPharma closely still see room for the stock to rise. Data as of Sep 8, 2026; for reference only and not investment advice.